title: Detection of leukemic cells in the CD34(+)CD38(-) bone marrow progenitor population in children with acute lymphoblastic leukemia.
abstract: Successful autologous hematopoietic stem cell (HSC) transplantation in childhood acute lymphoblastic leukemia (ALL) requires the ability to either selectively kill the leukemia cells or separate normal from leukemic HSC. Based on previous studies showing that more than 95% of childhood B-lineage ALL express CD38, this study evaluated whether normal CD34(+)CD38(-) progenitors from children with B-lineage ALL could be isolated by flow cytometry. CD34(+) cells from bone marrow samples from 10 children with B-lineage ALL were isolated at day 28 of treatment, when clinical remission had been attained. The CD34(+) progenitor cells were flow cytometrically sorted into CD34(+)CD38(+) and CD34(+)CD38(-) populations. The absolute numbers of CD34(+)CD38(-) cells that could be isolated ranged from 401 to 6245. The cells were then analyzed for the presence of clonotypic rearrangements of the T-cell receptor (TCR) Vdelta2-Ddelta3 locus. Only patients whose diagnostic marrow had an informative TCR Vdelta2-Ddelta3 rearrangement were included in this study. Detection thresholds were typically 10(-4) to 10(-5) leukemic cells in normal marrow. In 6 of 10 samples analyzed, the sorted CD34(+)CD38(-) cells had no detectable Vdelta2-Ddelta3 rearrangements. In 4 cases, the clonotypic leukemic Vdelta2-Ddelta3 rearrangement was detected in the CD34(+)CD38(-) population, indicating that the putative normal HSC population also contained leukemic cells. The data indicate that although most childhood ALL cells express CD34 and CD38, leukemic cells are also frequently present in the CD34(+)CD38(-) population. Therefore, strategies to isolate and transplant normal HSC from children with ALL will require a more stringent definition of the normal HSC than the CD34(+)CD38(-) phenotype. (Blood. 2001;97:3925-3930)
authors.affiliation: Divisions of Research Immunology/Bone Marrow Transplantation, Childrens Hospital Los Angeles, 4650 Sunset Blvd., Los Angeles, CA 90027, USA.
authors.forename: A A
authors.initials: AA
authors.lastname: George
authors.forename: J
authors.initials: J
authors.lastname: Franklin
authors.forename: K
authors.initials: K
authors.lastname: Kerkof
authors.forename: A J
authors.initials: AJ
authors.lastname: Shah
authors.forename: M
authors.initials: M
authors.lastname: Price
authors.forename: E
authors.initials: E
authors.lastname: Tsark
authors.forename: D
authors.initials: D
authors.lastname: Bockstoce
authors.forename: D
authors.initials: D
authors.lastname: Yao
authors.forename: N
authors.initials: N
authors.lastname: Hart
authors.forename: S
authors.initials: S
authors.lastname: Carcich
authors.forename: R
authors.initials: R
authors.lastname: Parkman
authors.forename: G M
authors.initials: GM
authors.lastname: Crooks
authors.forename: K
authors.initials: K
authors.lastname: Weinberg
mesh_terms: D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D015703:Antigens, CD; D018952:Antigens, CD34 / Q000032:analysis*; D000943:Antigens, Differentiation / Q000032:analysis*; D001402:B-Lymphocytes / Q000473:pathology; D015139:Blotting, Southern; D001853:Bone Marrow / Q000473:pathology; D016465:Bone Marrow Purging / Q000592:standards*; D002648:Child; D002999:Clone Cells; D004273:DNA, Neoplasm / Q000032:analysis; D005434:Flow Cytometry; D015321:Gene Rearrangement; D019676:Genes, T-Cell Receptor delta; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000276:immunology; D006801:Humans; D008562:Membrane Glycoproteins; D009244:NAD+ Nucleosidase / Q000032:analysis*; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000473:pathology*; D012074:Remission Induction
chemical_list: D015703:Antigens, CD; D018952:Antigens, CD34; D000943:Antigens, Differentiation; D004273:DNA, Neoplasm; D008562:Membrane Glycoproteins; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1